V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20164723 | 20063279 | 1.69 | 55.3 | Curative (C) | 2018-12-03 | 2018-12-14 | ECX | N | Y | CAPECITABINE + GEMCITABINE | 100370671 |
| 20164743 | 20063280 | 1.72 | 63 | Neo-adjuvant (N) | 2017-09-20 | 2017-09-20 | ECX | 02 | null | ECX | 100556276 |
| 20164745 | 20063281 | 1.65 | 78.9 | Adjuvant (A) | 2017-08-31 | 2017-09-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100938406 |
| 20164753 | 20063282 | 1.62 | 84 | Neo-adjuvant (N) | 2019-07-16 | 2019-07-20 | ECX | N | null | ECX | 100420190 |
| 20164759 | 20063283 | 1.74 | 70.25 | Neo-adjuvant (N) | 2019-11-25 | 2019-12-03 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101658959 |
| 20164763 | 20063284 | 1.72 | 78.2 | Adjuvant (A) | 2018-09-05 | 2018-09-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101491487 |
| 20164765 | 20063285 | 1.71 | 70.4 | null | 2019-07-09 | 2019-07-20 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 100774533 |
| 20164767 | 20063286 | 1.57 | 47.5 | null | 2020-06-24 | 2020-06-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100512004 |
| 20164768 | 20063287 | 1.79 | 69.7 | Palliative (P) | 2016-05-03 | 2016-05-16 | ECX | 02 | N | ECX | 101410732 |
| 20164772 | 20063288 | 1.77 | 73.9 | Palliative (P) | 2018-12-15 | 2018-12-29 | ECX | N | N | ECX | 100532860 |
| 20164773 | 20063289 | 1.71 | 61.2 | Adjuvant (A) | 2018-08-03 | 2018-08-09 | ECX | 2 | N | ECX | 100774427 |
| 20164775 | 20063290 | 1.77 | 71 | Adjuvant (A) | 2018-11-06 | 2018-11-24 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101728701 |
| 20164780 | 20063291 | 1.5 | 76.2 | Curative (C) | 2018-09-10 | 2018-09-27 | ECX | N | N | ECX | 101116149 |
| 20164785 | 20063292 | 1.57 | 62.6 | null | 2020-09-13 | 2020-09-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101576357 |
| 20164790 | 20063293 | 1.6 | 68.9 | 03 | 2016-08-09 | 2016-08-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100598323 |
| 20164794 | 20063294 | 1.57 | null | Adjuvant (A) | 2018-07-01 | 2018-07-14 | ECX | 02 | N | ECX | 101817180 |
| 20164795 | 20063295 | 1.71 | 77 | Adjuvant (A) | 2017-10-08 | 2017-10-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101490269 |
| 20164800 | 20063296 | 1.68 | 65.3 | Adjuvant (A) | 2017-08-23 | 2017-09-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101337882 |
| 20164801 | 20063297 | 1.58 | 83.1 | Palliative (P) | 2016-03-02 | 2016-03-03 | ECX | N | N | ECX | 101671039 |
| 20164806 | 20063298 | 1.65 | 70.2 | null | 2018-02-12 | 2018-02-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100980526 |
| 20164811 | 20063299 | 1.76 | 72.7 | Neo-adjuvant (N) | 2016-11-19 | 2016-12-05 | ECX | 2 | N | ECX | 101523379 |
| 20164814 | 20063300 | 1.74 | 103.2 | null | 2019-02-16 | 2019-03-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101867525 |
| 20164815 | 20063301 | 1.67 | 109 | Palliative (P) | 2016-07-08 | 2016-07-25 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100946724 |
| 20164818 | 20063302 | 1.55 | 78.3 | Neo-adjuvant (N) | 2017-09-28 | 2017-10-10 | ECX | N | N | ECX | 101617690 |
| 20164820 | 20063303 | 1.76 | 62.9 | Neo-adjuvant (N) | 2016-05-19 | 2016-06-01 | ECX | 02 | N | ECX | 101025893 |
| 20164827 | 20063304 | 1.7 | 67.7 | Palliative (P) | 2018-07-14 | 2018-07-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100881751 |
| 20164828 | 20063305 | null | null | Neo-adjuvant (N) | 2018-09-29 | 2018-09-30 | ECX | N | N | ECX | 100732673 |
| 20164833 | 20063306 | 1.51 | 55.5 | Curative (C) | 2016-07-25 | 2016-08-01 | ECX | N | null | ECX | 100892654 |
| 20164836 | 20063307 | 1.57 | 89.5 | Palliative (P) | 2018-12-20 | 2018-12-20 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100121012 |
| 20164837 | 20063308 | 1.64 | 60.8 | null | 2018-12-31 | 2019-01-02 | Gemcitabine + Capecitabine | 01 | N | CAPECITABINE + GEMCITABINE | 101030966 |
| 20164840 | 20063309 | 1.78 | 91.8 | Adjuvant (A) | 2016-03-04 | 2016-03-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100811749 |
| 20164845 | 20063310 | 1.7 | 65.5 | Neo-adjuvant (N) | 2019-03-20 | 2019-04-05 | ECX | N | N | ECX | 101029903 |
| 20164856 | 20063311 | 1.78 | 76.1 | Adjuvant (A) | 2016-12-31 | 2017-01-09 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100589405 |
| 20164858 | 20063312 | 1.6 | 79.4 | Palliative (P) | 2016-03-23 | 2016-04-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100427483 |
| 20164862 | 20063313 | 1.73 | 86.6 | Neo-adjuvant (N) | 2018-06-01 | 2018-06-01 | ECX | N | N | ECX | 100834458 |
| 20164869 | 20063314 | 1.69 | 59.95 | Disease modification (D) | 2017-01-21 | 2017-01-21 | ECX | N | N | ECX | 100427205 |
| 20164871 | 20063315 | 1.68 | 75.4 | Neo-adjuvant (N) | 2019-06-19 | 2019-07-10 | ECX | 02 | N | ECX | 100119854 |
| 20164872 | 20063316 | 1.58 | 62.4 | Neo-adjuvant (N) | 2019-09-23 | 2019-10-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101008731 |
| 20164874 | 20063317 | 1.76 | 86.6 | null | null | 2017-03-08 | Gemcitabine + Capecitabine | 02 | N | ECX | 100246107 |
| 20164891 | 20063318 | 1.62 | 73.9 | Curative (C) | 2019-11-14 | 2019-11-28 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101243429 |
| 20164893 | 20063319 | 1.49 | 67.65 | null | 2018-10-15 | 2018-10-19 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100097709 |
| 20164894 | 20063320 | 1.51 | 78.55 | null | 2019-08-08 | 2019-08-13 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101564605 |
| 20164896 | 20063321 | 1.69 | 92.1 | Palliative (P) | 2019-03-28 | 2019-04-24 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101310317 |
| 20164902 | 20063322 | 1.7 | 67.95 | Palliative (P) | 2018-12-16 | 2018-12-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101408777 |
| 20164912 | 20063323 | 1.64 | 76.3 | null | 2019-01-25 | 2019-01-31 | ECX | N | N | ECX | 100579826 |
| 20164921 | 20063324 | 1.65 | 64.4 | Neo-adjuvant (N) | 2018-08-29 | 2018-09-01 | ECX | null | N | CAPECITABINE + GEMCITABINE | 100481827 |
| 20164922 | 20063325 | 1.8 | 80 | Palliative (P) | 2018-12-24 | 2019-01-05 | ECX | 02 | N | ECX | 101441866 |
| 20164926 | 20063326 | 1.5 | 58.7 | Adjuvant (A) | 2020-07-07 | 2020-07-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100621029 |
| 20164929 | 20063327 | 1.57 | 73.7 | Palliative (P) | 2018-04-30 | 2018-05-01 | ECX | 02 | N | ECX | 101600945 |
| 20164933 | 20063328 | 1.7 | 70.3 | null | 2016-02-03 | 2016-02-18 | ECX | 2 | N | ECX | 100439961 |